November 5, 2026 — Silynxcom (NYSE American: SYNX) is expanding into the counter-drone defense market with the development of an AI-powered wearable detection and early-warning system designed to protect individual soldiers from unmanned aircraft threats. The prototype-stage technology uses acoustic signatures and artificial intelligence to passively detect approaching drones without relying on radio-frequency emissions, potentially allowing it to identify fiber-optic-guided drones that conventional RF-based detection systems may miss.
November 5, 2026 — SS Innovations International (NASDAQ: SSII) is strengthening its position in the emerging telerobotic surgery market as advances in surgical robotics and communications technology create new opportunities for remote medical procedures. The company’s SSi Mantra surgical robotic system has supported 195 robotic telesurgeries as of September 28, 2026, including cardiac procedures and operations performed across significant geographic distances.
November 5, 2026 — Earth Science Tech (OTCQB: ETST), a diversified holding company operating across healthcare, pharmacy, technology, telemedicine, real estate, and consumer products, is leveraging synergies among its subsidiaries to support long-term growth and generate dependable revenue. Its real estate and asset management subsidiary, Avenvi LLC, contributes to this strategy through its diversified real estate portfolio, property development expertise, and financing solutions for property purchasers.
November 5, 2026 — Disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising.
November 5, 2026 — Annovis Bio (NYSE: ANVS), a Phase 3 clinical-stage biotechnology company, announced the pricing of an underwritten public offering of 19 million common shares, pre-funded warrants to purchase up to 2 million shares and accompanying warrants to purchase up to 21 million shares. The combined offering price is $1 per common share and accompanying warrant, or $0.
November 5, 2026 — FingerMotion (NASDAQ: FNGR) together with Genius Group Limited (NYSE American: GNS) and BlueFlare Energy Solutions Inc. , announced a second binding agreement establishing a joint venture for the Brooks Corridor Campus Program, covering up to 100 megawatts (MW) of powered land and colocation campuses in Alberta, Canada.
November 5, 2026 — Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company targeting drug resistance in cancer, announced that it has received the 2026 Biotech Breakthrough Award for Cancer Immunology Solution of the Year for its investigational therapy ENV-105 (carotuximab). The award recognizes the company’s approach to overcoming treatment resistance in metastatic prostate cancer and non-small cell lung cancer by developing therapies designed to restore and extend the effectiveness of existing cancer treatments.
November 5, 2026 — Wrap Technologies, Inc. has appointed former New York City Police Department Deputy Commissioner Edward Delatorre Jr.
November 5, 2026 — A new scientific development could help electric vehicles cover more distance without carrying large battery packs. South Korean scientists have introduced a battery design improvement that could make future electric cars lighter, more efficient, and capable of lasting longer.
November 5, 2026 — New rules governing renewable energy funding are changing how clean energy projects compete for public support across Europe. Through updated auction requirements, financial agreements and stricter standards for developers, the European Union (EU) is seeking to expand renewable power while keeping costs under control.
November 5, 2026 — The U. S.
November 5, 2026 — The crypto market is entering the final weeks of 2026 under renewed pressure, with major digital assets struggling to attract sustained buying interest. Bitcoin and other leading tokens have weakened as investors respond to a combination of macroeconomic uncertainty, exchange-related concerns, and a broader retreat from riskier investments.
November 5, 2026 — The company is preparing proposals for at least four additional Texas data center projects, seeking potential customers for its developing Texatron(TM) fusion energy platform. American Fusion(TM) is pursuing the acquisition of North Texas property for a permanent research and testing campus designed to support future Texatron(TM) development.
November 5, 2026 — Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company operating a contract development and manufacturing organization (“CDMO”) alongside an immunology-focused therapeutic development platform, reported revenue of $2. 8 million for the nine months ended Sept.
November 5, 2026 — Uranium Energy (NYSE American: UEC) announced that its subsidiary, UEC US Uranium LLC, has entered into definitive long-term sales agreements with two U. S.
November 5, 2026 — This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.
November 5, 2026 — Mobilicom (NASDAQ: MOB), a provider of cybersecure solutions for drones and robotics, announced its participation as an official sponsor of UVID DroneTech 2026, the 14th International Conference on Unmanned Systems, scheduled for Nov. 12, 2026, at Expo Tel Aviv in Israel.
November 5, 2026 — OptimumBank Holdings (NYSE American: OPHC), the parent company of OptimumBank, announced that it will release its financial results for the third quarter ended Sept. 30, 2026, before the market opens on Friday, Nov.
November 5, 2026 — Annovis Bio (NYSE: ANVS) a Phase 3 clinical-stage biotechnology company, announced a proposed underwritten public offering of common stock or pre-funded warrants in lieu of common stock, together with accompanying warrants to purchase common stock. The securities will be issued separately but must be purchased together.
November 5, 2026 — This article has been disseminated on behalf of Energy Fuels Inc. and may include paid advertising.
